PUCHHEIM, Germany--(BUSINESS WIRE)--Sloning BioTechnology GmbH, technology leader in the emerging gene synthesis market and provider of unrivalled gene mutant libraries (SlonoMax™), will carry out a feasibility study together with bioMérieux. The aim of the project is to generate a large number of different gene variants of an essential enzyme to be used in diagnostic applications.
